I envy those who bought in the .50 range. Hopefully, we take off from here and the entry point becomes moot.
Yes...I believe that if we are dealing with the future of acute pain and inflammation management, all these entry points do become very moot.
Moot---shoot, man--where's my loot? How bout next week we give these sub 1.00 blues---the boot!